货号:GS40658
Sintilimab is a fully human monoclonal antibody targeting programmed cell death protein 1 (PD-1). It binds to PD-1 on T cells, blocking interaction with PD-L1/PD-L2 ligands to restore anti-tumor immunity. It is approved in China for the treatment of non-small cell lung cancer, Hodgkin's lymphoma, hepatocellular carcinoma, and other advanced solid tumors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物